ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Apomorphine Hydrochloride Market Research Report 2025
Published Date: June 2025
|
Report Code: QYRE-Auto-2C9445
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Apomorphine Hydrochloride Market Outlook 2022
BUY CHAPTERS

Global Apomorphine Hydrochloride Market Research Report 2025

Code: QYRE-Auto-2C9445
Report
June 2025
Pages:90
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Supernus Pharmaceuticals
Britannia Pharmaceuticals STADA
EVER Pharma
Evolan Pharma AB (PharmSwed)
Tianjin Tianwei Pharmaceutical
Sunovion
Stada Arzneimittel
Aguettant
Italfarmaco S.p.A.
Sumitomo Pharma
Hubei Keyi Pharma

The global market for Apomorphine Hydrochloride was valued at US$ 150 million in the year 2024 and is projected to reach a revised size of US$ 209 million by 2031, growing at a CAGR of 4.5% during the forecast period.

Apomorphine Hydrochloride Market

Apomorphine Hydrochloride Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Apomorphine Hydrochloride competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Apomorphine is a non-selective dopamine agonist which activates both D2-like and, to a much lesser extent, D1-like receptors. It also acts as an antagonist of 5-HT2 and α-adrenergic receptors with high affinity. The compound is historically a morphine decomposition product made by boiling morphine with concentrated acid, hence the -morphine suffix. Apomorphine does not actually contain morphine or its skeleton, nor does it bind to opioid receptors.
The classification of Apomorphine Hydrochloride includes Injection, Tablets, Thinfilm, etc and the proportion of Injection in 2019 is about 89.88%, and the proportion is in decreasing trend from 2020 to 2025. Apomorphine Hydrochloride is widely used through Parkinson Disease and Erectile Dysfunction. The most proportion of Apomorphine Hydrochloride is used for Parkinson Disease, and the sales proportion in 2019 is 89.88%. Europe is the largest consumption place, with a consumption market share nearly 54.19% in 2019. Following Europe, North America is the second largest consumption place with the consumption market share of 23.69%. Market competition is not intense. Supernus Pharmaceuticals, Britannia Pharmaceuticals STADA, Ever Pharma are the leaders of the industry, and they hold key technologies and patents, with high-end customers.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Apomorphine Hydrochloride, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Apomorphine Hydrochloride.
The Apomorphine Hydrochloride market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Apomorphine Hydrochloride market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Apomorphine Hydrochloride manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Apomorphine Hydrochloride Market Report

Report Metric Details
Report Name Apomorphine Hydrochloride Market
Accounted market size in year US$ 150 million
Forecasted market size in 2031 US$ 209 million
CAGR 4.5%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Injection
  • Tablets
  • Thinfilm
  • Nasal Powder (Pipeline)
Segment by Application
  • Parkinson Disease
  • Erectile Dysfunction
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Supernus Pharmaceuticals, Britannia Pharmaceuticals STADA, Ever Pharma, Evolan Pharma AB (PharmSwed), Tianjin Tianwei Pharmaceutical, Sunovion, STADA Arzneimittel, Aguettant, Italfarmaco, Sumitomo Pharma, Hubei Keyi Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Apomorphine Hydrochloride manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Apomorphine Hydrochloride in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Apomorphine Hydrochloride Market growing?

Ans: The Apomorphine Hydrochloride Market witnessing a CAGR of 4.5% during the forecast period 2025-2031.

What is the Apomorphine Hydrochloride Market size in 2031?

Ans: The Apomorphine Hydrochloride Market size in 2031 will be US$ 209 million.

What is the Apomorphine Hydrochloride Market share by application?

Ans: The most proportion of Apomorphine Hydrochloride is used for Parkinson Disease, and the sales proportion in 2019 is 89.88%.

What is the Apomorphine Hydrochloride Market share by region?

Ans: Europe is the largest consumption place, with a consumption market share nearly 54.19% in 2019.

Who are the main players in the Apomorphine Hydrochloride Market report?

Ans: The main players in the Apomorphine Hydrochloride Market are Supernus Pharmaceuticals, Britannia Pharmaceuticals STADA, Ever Pharma, Evolan Pharma AB (PharmSwed), Tianjin Tianwei Pharmaceutical, Sunovion, STADA Arzneimittel, Aguettant, Italfarmaco, Sumitomo Pharma, Hubei Keyi Pharma

What are the Application segmentation covered in the Apomorphine Hydrochloride Market report?

Ans: The Applications covered in the Apomorphine Hydrochloride Market report are Parkinson Disease, Erectile Dysfunction

What are the Type segmentation covered in the Apomorphine Hydrochloride Market report?

Ans: The Types covered in the Apomorphine Hydrochloride Market report are Injection, Tablets, Thinfilm, Nasal Powder (Pipeline)

Recommended Reports

Hydrochloride APIs

Neurology Treatment

Pain & Addiction Care

1 Apomorphine Hydrochloride Market Overview
1.1 Product Definition
1.2 Apomorphine Hydrochloride by Type
1.2.1 Global Apomorphine Hydrochloride Market Value Comparison by Type (2024 VS 2031)
1.2.2 Injection
1.2.3 Tablets
1.2.4 Thinfilm
1.2.5 Nasal Powder (Pipeline)
1.3 Apomorphine Hydrochloride by Application
1.3.1 Global Apomorphine Hydrochloride Market Value by Application (2024 VS 2031)
1.3.2 Parkinson Disease
1.3.3 Erectile Dysfunction
1.4 Global Apomorphine Hydrochloride Market Size Estimates and Forecasts
1.4.1 Global Apomorphine Hydrochloride Revenue 2020-2031
1.4.2 Global Apomorphine Hydrochloride Sales 2020-2031
1.4.3 Global Apomorphine Hydrochloride Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Apomorphine Hydrochloride Market Competition by Manufacturers
2.1 Global Apomorphine Hydrochloride Sales Market Share by Manufacturers (2020-2025)
2.2 Global Apomorphine Hydrochloride Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Apomorphine Hydrochloride Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Apomorphine Hydrochloride, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Apomorphine Hydrochloride, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Apomorphine Hydrochloride, Product Type & Application
2.7 Global Key Manufacturers of Apomorphine Hydrochloride, Date of Enter into This Industry
2.8 Global Apomorphine Hydrochloride Market Competitive Situation and Trends
2.8.1 Global Apomorphine Hydrochloride Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Apomorphine Hydrochloride Players Market Share by Revenue
2.8.3 Global Apomorphine Hydrochloride Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Apomorphine Hydrochloride Market Scenario by Region
3.1 Global Apomorphine Hydrochloride Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Apomorphine Hydrochloride Sales by Region: 2020-2031
3.2.1 Global Apomorphine Hydrochloride Sales by Region: 2020-2025
3.2.2 Global Apomorphine Hydrochloride Sales by Region: 2026-2031
3.3 Global Apomorphine Hydrochloride Revenue by Region: 2020-2031
3.3.1 Global Apomorphine Hydrochloride Revenue by Region: 2020-2025
3.3.2 Global Apomorphine Hydrochloride Revenue by Region: 2026-2031
3.4 North America Apomorphine Hydrochloride Market Facts & Figures by Country
3.4.1 North America Apomorphine Hydrochloride Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Apomorphine Hydrochloride Sales by Country (2020-2031)
3.4.3 North America Apomorphine Hydrochloride Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Apomorphine Hydrochloride Market Facts & Figures by Country
3.5.1 Europe Apomorphine Hydrochloride Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Apomorphine Hydrochloride Sales by Country (2020-2031)
3.5.3 Europe Apomorphine Hydrochloride Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Apomorphine Hydrochloride Market Facts & Figures by Region
3.6.1 Asia Pacific Apomorphine Hydrochloride Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Apomorphine Hydrochloride Sales by Region (2020-2031)
3.6.3 Asia Pacific Apomorphine Hydrochloride Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Apomorphine Hydrochloride Market Facts & Figures by Country
3.7.1 Latin America Apomorphine Hydrochloride Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Apomorphine Hydrochloride Sales by Country (2020-2031)
3.7.3 Latin America Apomorphine Hydrochloride Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Apomorphine Hydrochloride Market Facts & Figures by Country
3.8.1 Middle East and Africa Apomorphine Hydrochloride Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Apomorphine Hydrochloride Sales by Country (2020-2031)
3.8.3 Middle East and Africa Apomorphine Hydrochloride Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Apomorphine Hydrochloride Sales by Type (2020-2031)
4.1.1 Global Apomorphine Hydrochloride Sales by Type (2020-2025)
4.1.2 Global Apomorphine Hydrochloride Sales by Type (2026-2031)
4.1.3 Global Apomorphine Hydrochloride Sales Market Share by Type (2020-2031)
4.2 Global Apomorphine Hydrochloride Revenue by Type (2020-2031)
4.2.1 Global Apomorphine Hydrochloride Revenue by Type (2020-2025)
4.2.2 Global Apomorphine Hydrochloride Revenue by Type (2026-2031)
4.2.3 Global Apomorphine Hydrochloride Revenue Market Share by Type (2020-2031)
4.3 Global Apomorphine Hydrochloride Price by Type (2020-2031)
5 Segment by Application
5.1 Global Apomorphine Hydrochloride Sales by Application (2020-2031)
5.1.1 Global Apomorphine Hydrochloride Sales by Application (2020-2025)
5.1.2 Global Apomorphine Hydrochloride Sales by Application (2026-2031)
5.1.3 Global Apomorphine Hydrochloride Sales Market Share by Application (2020-2031)
5.2 Global Apomorphine Hydrochloride Revenue by Application (2020-2031)
5.2.1 Global Apomorphine Hydrochloride Revenue by Application (2020-2025)
5.2.2 Global Apomorphine Hydrochloride Revenue by Application (2026-2031)
5.2.3 Global Apomorphine Hydrochloride Revenue Market Share by Application (2020-2031)
5.3 Global Apomorphine Hydrochloride Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Supernus Pharmaceuticals
6.1.1 Supernus Pharmaceuticals Company Information
6.1.2 Supernus Pharmaceuticals Description and Business Overview
6.1.3 Supernus Pharmaceuticals Apomorphine Hydrochloride Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Supernus Pharmaceuticals Apomorphine Hydrochloride Product Portfolio
6.1.5 Supernus Pharmaceuticals Recent Developments/Updates
6.2 Britannia Pharmaceuticals STADA
6.2.1 Britannia Pharmaceuticals STADA Company Information
6.2.2 Britannia Pharmaceuticals STADA Description and Business Overview
6.2.3 Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Product Portfolio
6.2.5 Britannia Pharmaceuticals STADA Recent Developments/Updates
6.3 Ever Pharma
6.3.1 Ever Pharma Company Information
6.3.2 Ever Pharma Description and Business Overview
6.3.3 Ever Pharma Apomorphine Hydrochloride Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Ever Pharma Apomorphine Hydrochloride Product Portfolio
6.3.5 Ever Pharma Recent Developments/Updates
6.4 Evolan Pharma AB (PharmSwed)
6.4.1 Evolan Pharma AB (PharmSwed) Company Information
6.4.2 Evolan Pharma AB (PharmSwed) Description and Business Overview
6.4.3 Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Product Portfolio
6.4.5 Evolan Pharma AB (PharmSwed) Recent Developments/Updates
6.5 Tianjin Tianwei Pharmaceutical
6.5.1 Tianjin Tianwei Pharmaceutical Company Information
6.5.2 Tianjin Tianwei Pharmaceutical Description and Business Overview
6.5.3 Tianjin Tianwei Pharmaceutical Apomorphine Hydrochloride Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Tianjin Tianwei Pharmaceutical Apomorphine Hydrochloride Product Portfolio
6.5.5 Tianjin Tianwei Pharmaceutical Recent Developments/Updates
6.6 Sunovion
6.6.1 Sunovion Company Information
6.6.2 Sunovion Description and Business Overview
6.6.3 Sunovion Apomorphine Hydrochloride Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Sunovion Apomorphine Hydrochloride Product Portfolio
6.6.5 Sunovion Recent Developments/Updates
6.7 STADA Arzneimittel
6.7.1 STADA Arzneimittel Company Information
6.7.2 STADA Arzneimittel Description and Business Overview
6.7.3 STADA Arzneimittel Apomorphine Hydrochloride Sales, Revenue and Gross Margin (2020-2025)
6.7.4 STADA Arzneimittel Apomorphine Hydrochloride Product Portfolio
6.7.5 STADA Arzneimittel Recent Developments/Updates
6.8 Aguettant
6.8.1 Aguettant Company Information
6.8.2 Aguettant Description and Business Overview
6.8.3 Aguettant Apomorphine Hydrochloride Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Aguettant Apomorphine Hydrochloride Product Portfolio
6.8.5 Aguettant Recent Developments/Updates
6.9 Italfarmaco
6.9.1 Italfarmaco Company Information
6.9.2 Italfarmaco Description and Business Overview
6.9.3 Italfarmaco Apomorphine Hydrochloride Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Italfarmaco Apomorphine Hydrochloride Product Portfolio
6.9.5 Italfarmaco Recent Developments/Updates
6.10 Sumitomo Pharma
6.10.1 Sumitomo Pharma Company Information
6.10.2 Sumitomo Pharma Description and Business Overview
6.10.3 Sumitomo Pharma Apomorphine Hydrochloride Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Sumitomo Pharma Apomorphine Hydrochloride Product Portfolio
6.10.5 Sumitomo Pharma Recent Developments/Updates
6.11 Hubei Keyi Pharma
6.11.1 Hubei Keyi Pharma Company Information
6.11.2 Hubei Keyi Pharma Description and Business Overview
6.11.3 Hubei Keyi Pharma Apomorphine Hydrochloride Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Hubei Keyi Pharma Apomorphine Hydrochloride Product Portfolio
6.11.5 Hubei Keyi Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Apomorphine Hydrochloride Industry Chain Analysis
7.2 Apomorphine Hydrochloride Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Apomorphine Hydrochloride Production Mode & Process Analysis
7.4 Apomorphine Hydrochloride Sales and Marketing
7.4.1 Apomorphine Hydrochloride Sales Channels
7.4.2 Apomorphine Hydrochloride Distributors
7.5 Apomorphine Hydrochloride Customer Analysis
8 Apomorphine Hydrochloride Market Dynamics
8.1 Apomorphine Hydrochloride Industry Trends
8.2 Apomorphine Hydrochloride Market Drivers
8.3 Apomorphine Hydrochloride Market Challenges
8.4 Apomorphine Hydrochloride Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Supernus Pharmaceuticals
Britannia Pharmaceuticals STADA
EVER Pharma
Evolan Pharma AB (PharmSwed)
Tianjin Tianwei Pharmaceutical
Sunovion
Stada Arzneimittel
Aguettant
Italfarmaco S.p.A.
Sumitomo Pharma
Hubei Keyi Pharma
List of Tables
 Table 1. Global Apomorphine Hydrochloride Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Apomorphine Hydrochloride Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Apomorphine Hydrochloride Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Apomorphine Hydrochloride Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Apomorphine Hydrochloride Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Apomorphine Hydrochloride Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Apomorphine Hydrochloride Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Apomorphine Hydrochloride Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Apomorphine Hydrochloride, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Apomorphine Hydrochloride, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Apomorphine Hydrochloride, Product Type & Application
 Table 12. Global Key Manufacturers of Apomorphine Hydrochloride, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Apomorphine Hydrochloride by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Apomorphine Hydrochloride as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Apomorphine Hydrochloride Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Apomorphine Hydrochloride Sales by Region (2020-2025) & (K Units)
 Table 18. Global Apomorphine Hydrochloride Sales Market Share by Region (2020-2025)
 Table 19. Global Apomorphine Hydrochloride Sales by Region (2026-2031) & (K Units)
 Table 20. Global Apomorphine Hydrochloride Sales Market Share by Region (2026-2031)
 Table 21. Global Apomorphine Hydrochloride Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Apomorphine Hydrochloride Revenue Market Share by Region (2020-2025)
 Table 23. Global Apomorphine Hydrochloride Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Apomorphine Hydrochloride Revenue Market Share by Region (2026-2031)
 Table 25. North America Apomorphine Hydrochloride Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Apomorphine Hydrochloride Sales by Country (2020-2025) & (K Units)
 Table 27. North America Apomorphine Hydrochloride Sales by Country (2026-2031) & (K Units)
 Table 28. North America Apomorphine Hydrochloride Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Apomorphine Hydrochloride Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Apomorphine Hydrochloride Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Apomorphine Hydrochloride Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Apomorphine Hydrochloride Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Apomorphine Hydrochloride Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Apomorphine Hydrochloride Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Apomorphine Hydrochloride Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Apomorphine Hydrochloride Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Apomorphine Hydrochloride Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Apomorphine Hydrochloride Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Apomorphine Hydrochloride Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Apomorphine Hydrochloride Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Apomorphine Hydrochloride Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Apomorphine Hydrochloride Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Apomorphine Hydrochloride Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Apomorphine Hydrochloride Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Apomorphine Hydrochloride Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Apomorphine Hydrochloride Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Apomorphine Hydrochloride Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Apomorphine Hydrochloride Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Apomorphine Hydrochloride Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Apomorphine Hydrochloride Sales (K Units) by Type (2020-2025)
 Table 51. Global Apomorphine Hydrochloride Sales (K Units) by Type (2026-2031)
 Table 52. Global Apomorphine Hydrochloride Sales Market Share by Type (2020-2025)
 Table 53. Global Apomorphine Hydrochloride Sales Market Share by Type (2026-2031)
 Table 54. Global Apomorphine Hydrochloride Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Apomorphine Hydrochloride Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Apomorphine Hydrochloride Revenue Market Share by Type (2020-2025)
 Table 57. Global Apomorphine Hydrochloride Revenue Market Share by Type (2026-2031)
 Table 58. Global Apomorphine Hydrochloride Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Apomorphine Hydrochloride Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Apomorphine Hydrochloride Sales (K Units) by Application (2020-2025)
 Table 61. Global Apomorphine Hydrochloride Sales (K Units) by Application (2026-2031)
 Table 62. Global Apomorphine Hydrochloride Sales Market Share by Application (2020-2025)
 Table 63. Global Apomorphine Hydrochloride Sales Market Share by Application (2026-2031)
 Table 64. Global Apomorphine Hydrochloride Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Apomorphine Hydrochloride Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Apomorphine Hydrochloride Revenue Market Share by Application (2020-2025)
 Table 67. Global Apomorphine Hydrochloride Revenue Market Share by Application (2026-2031)
 Table 68. Global Apomorphine Hydrochloride Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Apomorphine Hydrochloride Price (USD/Unit) by Application (2026-2031)
 Table 70. Supernus Pharmaceuticals Company Information
 Table 71. Supernus Pharmaceuticals Description and Business Overview
 Table 72. Supernus Pharmaceuticals Apomorphine Hydrochloride Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Supernus Pharmaceuticals Apomorphine Hydrochloride Product
 Table 74. Supernus Pharmaceuticals Recent Developments/Updates
 Table 75. Britannia Pharmaceuticals STADA Company Information
 Table 76. Britannia Pharmaceuticals STADA Description and Business Overview
 Table 77. Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Product
 Table 79. Britannia Pharmaceuticals STADA Recent Developments/Updates
 Table 80. Ever Pharma Company Information
 Table 81. Ever Pharma Description and Business Overview
 Table 82. Ever Pharma Apomorphine Hydrochloride Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Ever Pharma Apomorphine Hydrochloride Product
 Table 84. Ever Pharma Recent Developments/Updates
 Table 85. Evolan Pharma AB (PharmSwed) Company Information
 Table 86. Evolan Pharma AB (PharmSwed) Description and Business Overview
 Table 87. Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Product
 Table 89. Evolan Pharma AB (PharmSwed) Recent Developments/Updates
 Table 90. Tianjin Tianwei Pharmaceutical Company Information
 Table 91. Tianjin Tianwei Pharmaceutical Description and Business Overview
 Table 92. Tianjin Tianwei Pharmaceutical Apomorphine Hydrochloride Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Tianjin Tianwei Pharmaceutical Apomorphine Hydrochloride Product
 Table 94. Tianjin Tianwei Pharmaceutical Recent Developments/Updates
 Table 95. Sunovion Company Information
 Table 96. Sunovion Description and Business Overview
 Table 97. Sunovion Apomorphine Hydrochloride Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Sunovion Apomorphine Hydrochloride Product
 Table 99. Sunovion Recent Developments/Updates
 Table 100. STADA Arzneimittel Company Information
 Table 101. STADA Arzneimittel Description and Business Overview
 Table 102. STADA Arzneimittel Apomorphine Hydrochloride Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. STADA Arzneimittel Apomorphine Hydrochloride Product
 Table 104. STADA Arzneimittel Recent Developments/Updates
 Table 105. Aguettant Company Information
 Table 106. Aguettant Description and Business Overview
 Table 107. Aguettant Apomorphine Hydrochloride Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Aguettant Apomorphine Hydrochloride Product
 Table 109. Aguettant Recent Developments/Updates
 Table 110. Italfarmaco Company Information
 Table 111. Italfarmaco Description and Business Overview
 Table 112. Italfarmaco Apomorphine Hydrochloride Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. Italfarmaco Apomorphine Hydrochloride Product
 Table 114. Italfarmaco Recent Developments/Updates
 Table 115. Sumitomo Pharma Company Information
 Table 116. Sumitomo Pharma Description and Business Overview
 Table 117. Sumitomo Pharma Apomorphine Hydrochloride Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 118. Sumitomo Pharma Apomorphine Hydrochloride Product
 Table 119. Sumitomo Pharma Recent Developments/Updates
 Table 120. Hubei Keyi Pharma Company Information
 Table 121. Hubei Keyi Pharma Description and Business Overview
 Table 122. Hubei Keyi Pharma Apomorphine Hydrochloride Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 123. Hubei Keyi Pharma Apomorphine Hydrochloride Product
 Table 124. Hubei Keyi Pharma Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Apomorphine Hydrochloride Distributors List
 Table 128. Apomorphine Hydrochloride Customers List
 Table 129. Apomorphine Hydrochloride Market Trends
 Table 130. Apomorphine Hydrochloride Market Drivers
 Table 131. Apomorphine Hydrochloride Market Challenges
 Table 132. Apomorphine Hydrochloride Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Apomorphine Hydrochloride
 Figure 2. Global Apomorphine Hydrochloride Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Apomorphine Hydrochloride Market Share by Type: 2024 & 2031
 Figure 4. Injection Product Picture
 Figure 5. Tablets Product Picture
 Figure 6. Thinfilm Product Picture
 Figure 7. Nasal Powder (Pipeline) Product Picture
 Figure 8. Global Apomorphine Hydrochloride Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Apomorphine Hydrochloride Market Share by Application: 2024 & 2031
 Figure 10. Parkinson Disease
 Figure 11. Erectile Dysfunction
 Figure 12. Global Apomorphine Hydrochloride Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Apomorphine Hydrochloride Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Apomorphine Hydrochloride Sales (2020-2031) & (K Units)
 Figure 15. Global Apomorphine Hydrochloride Average Price (USD/Unit) & (2020-2031)
 Figure 16. Apomorphine Hydrochloride Report Years Considered
 Figure 17. Apomorphine Hydrochloride Sales Share by Manufacturers in 2024
 Figure 18. Global Apomorphine Hydrochloride Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Apomorphine Hydrochloride Players: Market Share by Revenue in Apomorphine Hydrochloride in 2024
 Figure 20. Apomorphine Hydrochloride Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Apomorphine Hydrochloride Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Apomorphine Hydrochloride Sales Market Share by Country (2020-2031)
 Figure 23. North America Apomorphine Hydrochloride Revenue Market Share by Country (2020-2031)
 Figure 24. U.S. Apomorphine Hydrochloride Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Apomorphine Hydrochloride Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Apomorphine Hydrochloride Sales Market Share by Country (2020-2031)
 Figure 27. Europe Apomorphine Hydrochloride Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Apomorphine Hydrochloride Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Apomorphine Hydrochloride Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Apomorphine Hydrochloride Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Apomorphine Hydrochloride Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Apomorphine Hydrochloride Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Apomorphine Hydrochloride Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Apomorphine Hydrochloride Revenue Market Share by Region (2020-2031)
 Figure 35. China Apomorphine Hydrochloride Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Apomorphine Hydrochloride Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Apomorphine Hydrochloride Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Apomorphine Hydrochloride Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Apomorphine Hydrochloride Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Taiwan Apomorphine Hydrochloride Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Apomorphine Hydrochloride Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Apomorphine Hydrochloride Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Apomorphine Hydrochloride Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Philippines Apomorphine Hydrochloride Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Apomorphine Hydrochloride Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Apomorphine Hydrochloride Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Apomorphine Hydrochloride Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Apomorphine Hydrochloride Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Apomorphine Hydrochloride Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Apomorphine Hydrochloride Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Apomorphine Hydrochloride Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Apomorphine Hydrochloride Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Apomorphine Hydrochloride Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. UAE Apomorphine Hydrochloride Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Apomorphine Hydrochloride by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Apomorphine Hydrochloride by Type (2020-2031)
 Figure 57. Global Apomorphine Hydrochloride Price (USD/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Apomorphine Hydrochloride by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Apomorphine Hydrochloride by Application (2020-2031)
 Figure 60. Global Apomorphine Hydrochloride Price (USD/Unit) by Application (2020-2031)
 Figure 61. Apomorphine Hydrochloride Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Apomorphine Hydrochloride Injection Market Insights Forecast to 2030
Global Apomorphine Delivery Device Market Insights Forecast to 2030
Global Dopamine Agonists Market Research Report 2024
Opioid Receptor Agonist Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Dopamine Receptor Agonists Market Research Report 2025
Global Dopamine Receptor Agonists For PD Market Research Report 2025
Global Tiapride Market Insights Forecast to 2030
Global Dopamine Hydrochloride API Market Research Report 2025
Global Lurasidone Hydrochloride API Market Research Report 2024
Global Tiapride Hydrochloride Tablets Market Research Report 2024
Hydromorphone Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Opioids Agonist Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hydromorphone Hydrochloride Injection Market Research Report 2024
Global Selegiline Hydrochloride Market Research Report 2024
Global Agomelatine Market Research Report 2024
Global Dopamine Impurity Market Research Report 2025
Global Norepinephrine Noradrenaline Market Insights Forecast to 2030
Global Imipramine HCL API Market Research Report 2025
Global Levodopa Market Insights Forecast to 2030
Global Opioid Drugs Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions